MA47129A - Sel de composé pipéridine substitué - Google Patents

Sel de composé pipéridine substitué

Info

Publication number
MA47129A
MA47129A MA047129A MA47129A MA47129A MA 47129 A MA47129 A MA 47129A MA 047129 A MA047129 A MA 047129A MA 47129 A MA47129 A MA 47129A MA 47129 A MA47129 A MA 47129A
Authority
MA
Morocco
Prior art keywords
piperidine compound
substituted piperidine
compound salt
salt
substituted
Prior art date
Application number
MA047129A
Other languages
English (en)
Inventor
Morihiro Mitsuya
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA47129A publication Critical patent/MA47129A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA047129A 2016-12-22 2017-12-22 Sel de composé pipéridine substitué MA47129A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016249767 2016-12-22

Publications (1)

Publication Number Publication Date
MA47129A true MA47129A (fr) 2019-10-30

Family

ID=62626798

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047129A MA47129A (fr) 2016-12-22 2017-12-22 Sel de composé pipéridine substitué

Country Status (6)

Country Link
US (1) US11028069B2 (fr)
EP (1) EP3560919A4 (fr)
JP (1) JP6937322B2 (fr)
CN (1) CN110088097A (fr)
MA (1) MA47129A (fr)
WO (1) WO2018117267A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7227968B2 (ja) 2018-05-29 2023-02-22 大鵬薬品工業株式会社 抗腫瘍剤及び腫瘍治療方法
CN112239465A (zh) 2019-07-16 2021-01-19 微境生物医药科技(上海)有限公司 极光激酶抑制剂及其用途
JPWO2022114135A1 (fr) * 2020-11-26 2022-06-02
TW202321215A (zh) * 2021-07-28 2023-06-01 大陸商北京加科思新藥研發有限公司 Aurora a 選擇性抑制劑的多晶型及其用途
WO2024088193A1 (fr) * 2022-10-26 2024-05-02 Js Innopharm (Suzhou) Ltd. Association d'aurora a et d'inhibiteurs de parp pour le traitement de cancers
WO2024088192A1 (fr) * 2022-10-26 2024-05-02 Js Innopharm (Suzhou) Ltd. Inhibiteur d'aurora a destiné à être utilisé dans des traitements anticancéreux

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs
TWI485146B (zh) 2012-02-29 2015-05-21 Taiho Pharmaceutical Co Ltd Novel piperidine compounds or salts thereof
US9012475B2 (en) 2013-08-27 2015-04-21 Taiho Pharmaceutical Co., Ltd. Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor

Also Published As

Publication number Publication date
JP6937322B2 (ja) 2021-09-22
WO2018117267A1 (fr) 2018-06-28
EP3560919A1 (fr) 2019-10-30
CN110088097A (zh) 2019-08-02
EP3560919A4 (fr) 2020-05-13
JPWO2018117267A1 (ja) 2019-10-31
US20200087282A1 (en) 2020-03-19
US11028069B2 (en) 2021-06-08

Similar Documents

Publication Publication Date Title
EP3366684A4 (fr) Composé hétérocyclique
EP3438109A4 (fr) Composé hétérocyclique
EP3498693A4 (fr) Composé hétérocyclique
EP3360864A4 (fr) Composé pyrimidine
DK3436444T3 (da) Heterocyklisk forbindelse
EP3381896A4 (fr) Nouveau composé de biphényle ou un sel de celui-ci
EP3689879A4 (fr) Composé hétérocyclique
EP3327019A4 (fr) Composé hétérocyclique
EP3342777A4 (fr) Composé benzyle
MA45185A (fr) Composé de sulfonamide ou son sel
MA50466A (fr) Nouveau composé de biphényle ou sel de celui-ci
EP3354638A4 (fr) Composé de phtalonitrile
EP3366679A4 (fr) Composé hétérocyclique
EP3444239A4 (fr) Composé hétérocyclique
MA47129A (fr) Sel de composé pipéridine substitué
EP3560926A4 (fr) COMPOSÉ INHIBITEUR DE Brk
EP3372604A4 (fr) Composé hétérocyclique condensé
EP3299355A4 (fr) Composé de phtalonitrile
EP3533799A4 (fr) Composé
EP3438103A4 (fr) Composé de griséofulvine
BR112017017193A2 (pt) compostos herbicidas
EP3424905A4 (fr) Composé hétérocyclique
EP3372588A4 (fr) Composé de pyrimidine
LT3597189T (lt) Kristaliniai junginia
EP3404023A4 (fr) Composé bihétérocyclique